Medpace Holdings, Inc. (MEDP)

Nasdaq · Healthcare · Diagnostics & Research
$610.54-3.70%As of 2026-11-22 · USD
Last session low $606.73Last session high $633.87
52-week low $373.0052-week high $693.97
Market cap
$17.08B
Sector
Healthcare
P/E (TTM)
33.9x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)39.6In the neutral range (30 to 70)
MACD (12, 26, 9)0.34Below its signal line (6.13); histogram -5.79
Bollinger %B (20, 2)-19%Below the lower band (623.28 to 690.88)
SMA 20657.08Price is 7.1% below
SMA 50634.72Price is 3.8% below
SMA 200533.62Price is 14.4% above
ATR (20)3.21% of priceAverage true range per day
52-week position74%In the upper part of the 373.00 to 693.97 range

About Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.

Insider filings, 90 daysNo purchases and 18 sales (about $145.9M).
Latest fiscal yearEnded 2025-12-31: revenue of $2.53B and an operating margin of 21.1%.

More in Diagnostics & Research